Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation

25 Oct 2014

Abstract excerpt

•Molecular testing may play a role in the determination of targeted therapy treatment options.•Targeted therapy provides treatment options for recurrent cervical cancer.•MEK inhibitor is a treatment option for recurrent cervical cancer in a patient with KRAS mutation.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26075998
DOI: 10.1016/j.gore.2014.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutationPMID 26075998Read ↗

Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series.Semantic proximity Read ↗

Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.Semantic proximity Read ↗

Comparative genomics of high grade neuroendocrine carcinoma of the cervix.Semantic proximity Read ↗

Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.Semantic proximity Read ↗

The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervixSemantic proximity Read ↗

BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.Semantic proximity Read ↗

Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine NeoplasiaSemantic proximity Read ↗

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors.Semantic proximity Read ↗

BRAFV600E mutation: A promising target in colorectal neuroendocrine carcinoma.Semantic proximity Read ↗

RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study.Semantic proximity Read ↗

BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.Semantic proximity Read ↗

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.